Didier Roche

This inventor holds 16 USPTO granted patents and 3 published patent applications, plus 7 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Merck Patent Gmbh, Centre National De La Recherche Scientifique, Edelris. Active years: 2009-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Didier Roche. Retrieved from https://idiyas.com/inventor/didier-roche

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 3)

% Patents Active = 31.3

CIPO Patents = 7 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 12(Granted Patents)

Location History:

Lyons, FR (2009)
Saclay, FR (2009 - 2013)
Ecully, FR (2013 - 2020)

Company Filing History:

Centre National De La Recherche Scientifique

Ens-Ecole Normale Superieure De Lyon

patents

5. 2 out of 1,248

Merck Patent Gesellschaft MIT Beschrankter Haftung

patents

6. 2 out of 1,853

National Institute of Health and Medical Research

University Claude Bernard - Lyon 1

patents

9. 1 out of 387

Bayer Pharma Aktiengesellschaft

Merck Patent Gesellschaft

patents

where one patent can have more than one assignee

Years Active: 2009-2020

Loading Chart...

Areas of Expertise:

Furane Derivatives

Hepatitis B Treatment

11-Beta-HSD1 Inhibitors

Benzofurane

Benzothiophene

Benzothiazol Derivatives

NIP Thiazole Derivatives

Pyrrolidino-Cyclopropane

2-Adamantylurea Derivatives

Guanidine Derivatives

Carboxylic Acids

Diabetes Treatment

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10654818 - Furane derivatives as inhibitors of ATAD2 (2020-05-19),

2. 10071108 - Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection (2018-09-11),

3. 9895380 - Methods and pharmaceutical compositions for the treatment of hepatitis B virus infection (2018-02-20),

4. 8765728 - [1,5]-diazocin derivatives (2014-07-01),

5. 8586577 - Diazepane acetamide derivatives as selective 11B-HSD1 inhibitors (2013-11-19),

6. 8575161 - Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators (2013-11-05),

7. 8546575 - NIP thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydroge-nase-1 (2013-10-01),

8. 8486964 - Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors (2013-07-16),

9. 8470849 - 7-azaindole derivatives as selective 11-β-hydroxysteroid dehydrogenase type 1 inhibitors (2013-06-25),

10. 8466200 - 2-adamantylurea derivatives as selective 11β-HSD1 inhibitors (2013-06-18),

11. 8242107 - Diazepane-acetamide derivatives as selective 11β-HSD1 inhibitors (2012-08-14),

12. 8188288 - 2-adamantylurea derivatives as selective 11beta-HSD1 inhibitors (2012-05-29),

13. 8183265 - 2-adamantyl-butyramide derivatives as selective 11β-HSD1 inhibitors (2012-05-22),

14. 7754740 - [object Object] (2010-07-13),

15. 7582656 - Guanidine derivatives and therapeutic uses thereof (2009-09-01),

Title: Celebrating the Innovations of Inventor Didier Roche

Introduction

Didier Roche, a distinguished inventor based in Saclay, France, is known for his significant contributions to the field of pharmaceutical innovations. With a remarkable portfolio of 16 patents, Roche has made notable advancements in medical research and treatment methodologies.

Latest Patents

Among his latest innovations, Roche has developed furane derivatives as inhibitors of ATAD2. This invention involves a specific formula that provides a novel approach to inhibiting ATAD2 and outlines a process for the preparation and utilization of these compounds. Additionally, Roche has worked on methods and pharmaceutical compositions for the treatment of hepatitis B virus infection. This invention focuses on farnesoid X receptor (FXR) agonists and their therapeutic applications in treating individuals afflicted by the hepatitis B virus.

Career Highlights

Roche's career highlights include his collaborations with renowned organizations such as Merck Patent GmbH and the Institut National de la Santé et de la Recherche Médicale. His role in these institutions has facilitated his groundbreaking research and the development of his patented inventions.

Collaborations

Throughout his career, Didier Roche has collaborated with esteemed colleagues, including Denis Carniato and Christine G Charon. These partnerships have played a crucial role in enhancing the scope and impact of his research and innovations in the pharmaceutical industry.

Conclusion

In conclusion, Didier Roche stands out as an influential inventor in the realm of pharmaceutical sciences. His innovative work and a strong patent portfolio demonstrate his dedication to advancing medical treatments, showcasing the importance of innovation in improving health outcomes.

Profile summary based on public USPTO records.